Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxycodone versus sufentanil for postoperative analgesia after laparoscopic myomectomy
ChiCTR2600133051Phase 4Not yet recruiting
- Sponsor
- Shenzhen People's Hospital
- Start
- Jun 2026
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in postoperative pain comparing Oxycodone group with Sufentanil group (2 arms). Primary endpoints: VAS pain scores for resting incision and visceral pain, and movement-related incision and visceral pain and Pain score during postoperative oxytocin administration. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
oxycodonesufentanil
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2600133051.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600133051.